Ferritin Nanocages: A Novel Platform for Biomedical Applications

Abstract

Ferritin is a ubiquitous iron storage protein responsible for maintaining the iron homeostasis in living organism and thereby protects the cell from oxidative damage. The ferritin protein cages have been used as a reaction vessel for the synthesis of various non-native metallic nanoparticles inside its core and also used as a nanocarrier for various applications. Lack of suitable non-viral carrier for targeted delivery of anticancer drugs and imaging agents is the major problem in cancer therapy and diagnosis. The pH dependent reversible assembling and disassembling property of ferritin renders it as a suitable candidate for encapsulating a variety of anticancer drugs and imaging probes. Ferritins external surface is chemically and genetically modifiable which can serve as attachment site for tumor specific targeting peptides or moieties. Recent studies, further establishes ferritin as a multifunctional nanocarrier for targeted cancer diagnosis and therapy. Moreover, the biological origin of these protein cages makes it a biocompatible nanocarrier that stabilizes and protects the enclosed particles from the external environment without provoking any toxic or immunogenic responses. This review mainly focuses on the application of ferritin nanocages as a novel non-viral nanocarrier for cancer therapy and it also highlights various biomedical applications of ferritin nanocages.

Biomimetic nanomaterials: Development of protein coated nanoceria as a potential antioxidative nano-agent for the effective scavenging of reactive oxygen species in vitro and in zebrafish model

“…In recent years, protein based nanoparticles have gained remarkable interest due to its unique functionalities and probable applications in the field of nanotechnology and nanomedicine [33][34][35][36]. Moreover, the amphiphilic nature of proteins allows them to interact with both the nanoparticles and the surrounding solvent system.…”

Tumor-targeted folate-decorated albumin-stabilised silver nanoparticles induce apoptosis at low concentration in human breast cancer cells

“…In this regard, protein based nanoparticles have been emerged as a potential candidate for therapeutic applications because of their high biocompatibility, high water solubility, biodegradability, good availability, easy surface modification, non-toxic and nonimmunogenic properties [1,[12][13]. With the success of FDA approved Abraxane (albumin based drug nano-formulation), albumin based nanoparticles emerged as a potential candidate in the field of nanotechnology and cancer therapy [14][15][16][17].…”

“…This provokes a need to develop a safe and effective system for efficient delivery of Ag NPs with enhanced therapeutic efficacy at lowest possible Ag NPs concentrations and thereby provide an alternative mode of cancer therapy.In this regard, protein based nanoparticles have been emerged as a potential candidate for therapeutic applications because of their high biocompatibility, high water solubility, biodegradability, good availability, easy surface modification, non-toxic and nonimmunogenic properties [1,[12][13]. But the cytotoxicity and genotoxicity associated with Ag NPs at higher concentration hindered its applications in the field of cancer therapy.…”

Nanocontainer in der Analytik

“…B. aus mesoporçsem Siliciumoxid, Polymeren, [6] Proteinen, [7] DNA, [8] Gold, [9] Metalloxiden [10] oder Kohlenstoff. [7,29] Ausdem Jahr 2012 liegt auch ein etwas allgemeinerer Überblick über nanoporçse Materialien in der Bioanalytik vor,d er von Dai und Ju verçffentlicht wurde. Die Poren und Hohlräume erlauben beispielsweise den Einschluss von Farbstoffen, Wirkstoffen oder Nanopartikeln, sie kçnnen aber auch als begrenzte Umgebung fürb iologische oder chemische Reaktionen wirken.…”